Infertility in India is simultaneously a massive problem and an underreported one. Millions of couples struggle in silence — partly from stigma, partly from limited awareness, partly from a healthcare system that still treats infertility as a luxury concern rather than a medical condition.

This article presents the actual data: how common infertility is in India, what's causing it, how the fertility treatment landscape has changed, and what this means for you. No sugar-coating, no scare tactics — just the numbers and what they mean.

Key Takeaways

  • India has approximately 27.5 million infertile couples — one of the highest absolute numbers globally
  • India's infertility prevalence (~15-20% of couples) is comparable to global averages, but reporting and treatment-seeking remain significantly lower
  • Both male and female factors contribute equally — but male infertility remains significantly underdiagnosed in India
  • Urban India's fertility clinics are growing rapidly — 3,000+ registered clinics under the ART Act 2021
  • The ART Act 2021 has introduced patient protections and data reporting requirements that didn't exist before

How Many Couples in India Face Infertility?

This sounds like it should have a precise answer. It doesn't — because India lacks a comprehensive national infertility registry. But here are the best available estimates:

Source: ICMR (Indian Council of Medical Research) · Estimate: 10-15% of couples of reproductive age

Source: WHO Global Study (2023) · Estimate: India: ~17.8% infertility prevalence (historical data)

Source: India-specific studies (aggregated) · Estimate: 15-20% of couples trying to conceive

Source: Absolute number (ICMR, 2019 estimates) · Estimate: ~27.5 million infertile couples in India

Sources: ICMR-NIN; WHO Infertility Prevalence Estimates 1990–2021 (Mascarenhas et al.); Gurunath et al., Human Reproduction, 2011

To put 27.5 million in context: that's more infertile couples than the entire population of Australia.

India's Regional Variations

Infertility rates vary significantly across India:

Region: Central India (UP, Bihar, MP, Rajasthan) · Notes: Higher rates attributed to poor nutrition, infections, limited healthcare access

Region: South India (Karnataka, AP, Tamil Nadu) · Notes: Strong fertility clinic presence; higher treatment-seeking

Region: Maharashtra, West Bengal · Notes: Urban-rural divide within states

Region: Northeast India · Notes: Limited data; lower clinic density

A notable finding from multiple India-based studies: primary infertility (never conceived) is roughly as common as secondary infertility (can't conceive again after one birth). Both are significant — and secondary infertility is often underrecognized.

What's Causing Infertility in India?

The causes of infertility in India broadly mirror global patterns, but with some India-specific emphases:

Female Causes (Indian Context)

Cause: Ovulation disorders (PCOS, hypothalamic dysfunction) · Approximate % of Female Infertility Cases: 25-30%

Cause: Tubal disease (from infections, PID, STIs) · Approximate % of Female Infertility Cases: 25-35%

Cause: Endometriosis · Approximate % of Female Infertility Cases: 10-15%

Cause: Uterine factors (fibroids, polyps, congenital anomalies) · Approximate % of Female Infertility Cases: 10-15%

Cause: Diminished ovarian reserve · Approximate % of Female Infertility Cases: 5-10%

Cause: Unexplained · Approximate % of Female Infertility Cases: 10-15%

Cause: Other · Approximate % of Female Infertility Cases: 5-10%

Sources: FOGSI (Federation of Obstetric and Gynaecological Societies of India); Gnoth et al.; India-specific cohort studies

India-specific note on tubal disease: India has a higher rate of tubal factor infertility than high-income countries — historically attributed to higher rates of pelvic infections, STIs, and complications from unsafe abortions. This has declined with better infection treatment, but tubal blockage remains disproportionately common compared to Western studies.

PCOS prevalence: India has one of the highest PCOS prevalence rates in the world — estimated at 20-22% of women of reproductive age (vs. a global estimate of ~10-13%). Some studies cite even higher rates in Indian urban populations. The reasons are not fully understood but likely include genetic factors and the metabolic profile of South Asians (higher insulin resistance at lower BMI).

Male Causes (Indian Context)

Finding: Oligospermia (low sperm count) · Approximate Prevalence Among Infertile Indian Men: 25-30%

Finding: Asthenospermia (low motility) · Approximate Prevalence Among Infertile Indian Men: 20-25%

Finding: Combined defects (count + motility + morphology) · Approximate Prevalence Among Infertile Indian Men: 20-30%

Finding: Azoospermia (no sperm) · Approximate Prevalence Among Infertile Indian Men: 10-15%

Finding: Normal SA with elevated DNA fragmentation · Approximate Prevalence Among Infertile Indian Men: 10-20%

Sources: Dada et al., Indian Journal of Medical Research; Sharlip et al., Fertility and Sterility

The male infertility silence problem: In India, male infertility is significantly underdiagnosed because of social stigma. Studies suggest that in approximately 40-50% of infertile couples, there is a male-factor contribution — either alone or combined with female factors. Yet in clinical practice in India, the woman is typically evaluated first and most thoroughly.

This has real consequences: couples undergo months of female workup before the (often treatable) male factor is identified. Normalizing male fertility evaluation as a first step is one of the most impactful improvements possible in India's fertility care landscape.

The Lifestyle Factors Driving Rising Infertility

Several trends are associated with increasing infertility rates in urban India:

Delayed marriage and childbearing: Average age of first marriage in urban India has risen from ~22 years (1990s) to ~26-28 years (2020s). First pregnancy attempts are now frequently in the late 20s to mid-30s. Fertility naturally declines with age, so this structural shift increases the population experiencing age-related fertility challenges.

Obesity and metabolic syndrome: India has among the fastest-growing obesity rates in the world, particularly in urban areas. Obesity is associated with PCOS, hormonal disruption, sperm quality decline, and reduced IVF success rates.

Stress: Chronic psychological stress doesn't cause infertility, but it activates the HPA axis, which can suppress GnRH pulsatility — the hormonal signal that drives ovulation. Stress management isn't a cure, but it's a legitimate health consideration.

Environmental exposures: Exposure to endocrine-disrupting chemicals (pesticides, plastics, air pollution) is associated with sperm quality decline in multiple studies. India's high particulate air pollution in major cities is increasingly scrutinized in reproductive research.

Sexually transmitted infections: Undiagnosed chlamydial infections, in particular, cause tubal scarring without symptoms. STI rates in India are difficult to measure accurately, but pelvic inflammatory disease (a common consequence) remains a significant contributor to tubal factor infertility.

The Fertility Treatment Landscape in India

A Rapidly Growing Industry

India's ART (Assisted Reproductive Technology) industry has grown dramatically over the last decade:

Metric: Registered ART clinics (ART Act 2021) · Data: 3,000+ (as of 2025)

Metric: IVF cycles performed annually (estimate) · Data: 250,000–300,000 cycles

Metric: Annual growth rate · Data: ~15-20% per year

Metric: India's global IVF rank · Data: One of the top 3 markets globally by volume

India has become a destination for medical tourism in fertility — partly because of cost (IVF in India costs ₹1.2–2.5 lakh vs. ₹10–20 lakh equivalent in the UK/US), and partly because of a large, skilled specialist workforce.

Access Disparities

The growth is concentrated in urban centers:

  • Metro cities (Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Kolkata): Dense clinic presence, competitive pricing, multiple subspecialty options
  • Tier 2 cities (Pune, Ahmedabad, Jaipur, Lucknow, Chandigarh, Kochi): Growing clinic presence; more limited subspecialty care
  • Rural India: Severely limited. Most rural couples must travel to cities, adding significant cost and logistical burden to an already stressful journey

This access gap means that the fertility crisis is borne disproportionately by lower-income and rural couples, who face both higher infertility rates (from infections, nutrition, limited preventive care) and lower access to treatment.

The Private vs. Public Divide

Government hospitals with ART services exist (AIIMS Delhi, JIPMER Puducherry, and some state teaching hospitals), but capacity is extremely limited — waiting lists can be months to years. The overwhelming majority of ART in India is provided by private clinics.

The ART Act 2021: What Changed

The Assisted Reproductive Technology (Regulation) Act, 2021 was a landmark piece of legislation that brought India's fertility clinic industry under regulatory oversight for the first time. Before 2021, the industry was essentially self-regulated.

Key provisions of the ART Act 2021:

Provision: Mandatory registration · What It Means for Patients: All ART clinics must be registered; unregistered clinics are illegal

Provision: Standard of care requirements · What It Means for Patients: Clinics must maintain minimum infrastructure and personnel standards

Provision: Patient informed consent · What It Means for Patients: Explicit, documented consent required for all procedures

Provision: Data reporting · What It Means for Patients: Clinics must report outcomes data to the national registry

Provision: Prohibition of sex selection · What It Means for Patients: Selection based on sex (except for sex-linked diseases) is prohibited

Provision: Donor anonymity · What It Means for Patients: Donor gametes (eggs/sperm) must come from registered banks; donor identities are maintained in a national registry

Provision: Patient rights · What It Means for Patients: Right to full information, second opinion, and complaint mechanism

Provision: Criminal penalties · What It Means for Patients: Violations carry criminal penalties, not just administrative fines

For patients, the most immediately relevant provisions are:

  1. 1You can check whether a clinic is registered
  2. 2You have a right to data on outcomes
  3. 3You have a right to full informed consent before any procedure
  4. 4You can file a complaint with the State ART Authority if your rights are violated

For a full guide to your rights under the ART Act 2021, see our article Your Rights as a Patient Under the ART Act.

What the Data Shows About Treatment Success

India doesn't yet have a comprehensive public outcomes registry (it's being developed as part of the ART Act implementation), but available data from large clinics and published studies gives a reasonable picture:

IVF Success Rates in India (Per Cycle, Clinical Pregnancy)

Age Group: Under 30 · Clinical Pregnancy Rate (Per Cycle): 45–55% · Live Birth Rate (Per Cycle, Estimated): 38–48%

Age Group: 30–34 · Clinical Pregnancy Rate (Per Cycle): 40–50% · Live Birth Rate (Per Cycle, Estimated): 33–43%

Age Group: 35–37 · Clinical Pregnancy Rate (Per Cycle): 30–40% · Live Birth Rate (Per Cycle, Estimated): 23–33%

Age Group: 38–40 · Clinical Pregnancy Rate (Per Cycle): 20–30% · Live Birth Rate (Per Cycle, Estimated): 15–22%

Age Group: 41–42 · Clinical Pregnancy Rate (Per Cycle): 10–15% · Live Birth Rate (Per Cycle, Estimated): 7–12%

Age Group: Over 42 · Clinical Pregnancy Rate (Per Cycle): 5–10% (with own eggs) · Live Birth Rate (Per Cycle, Estimated): 3–7%

Sources: FOGSI; published data from leading Indian fertility centers; ICMR estimates

Critical note on how clinics report success rates: Many clinics in India report "clinical pregnancy rate" (heartbeat confirmed on ultrasound at 6-8 weeks) rather than "live birth rate" (a healthy baby delivered). These numbers can differ significantly — clinical pregnancy includes pregnancies that later miscarry. Always ask for live birth rate per egg retrieval when evaluating a clinic.

For a full guide to understanding and evaluating clinic success rate claims, see our article IVF Success Rates in India: How Clinics Game the Numbers.

The Stigma Problem

No discussion of infertility in India is complete without addressing stigma — because it drives much of the delay, suffering, and suboptimal care that infertile couples experience.

In India, infertility continues to be viewed in many communities as:

  • A woman's problem, not a couple's
  • A source of shame, particularly for women
  • Something to be hidden from family (at least until a solution is found)
  • Amenable to spiritual or traditional remedies before medical intervention

These beliefs have real consequences:

  • Women are blamed and pressured while male factors go unexamined
  • Couples delay seeking medical care due to shame
  • Women undergo unnecessary procedures before the male is tested
  • Psychological suffering is compounded by social isolation

What is changing:

  • Urban, educated couples are increasingly seeking care earlier and more openly
  • Online communities (WhatsApp groups, forums) have created private spaces for sharing
  • Media representation of IVF and fertility challenges is slowly normalizing the topic
  • The ART Act 2021, by bringing fertility treatment into regulated healthcare, signals a societal acknowledgment that infertility is a medical condition

The change is real but slow. If you're reading this, you're already ahead of the stigma.

What This Means for You

If you're struggling with infertility, the data says:

  1. 1You are not alone. Fifteen to twenty percent of couples face this. You are in a silent majority.
  2. 2The help you need exists. India has a large, growing, increasingly regulated fertility treatment sector. Three thousand clinics. Hundreds of thousands of cycles per year. The expertise is there.
  3. 3Getting evaluated early is medically justified. Especially if you're 35 or older, or have any of the warning signs described in our article on [when to see a fertility specialist](when-to-see-fertility-specialist).
  4. 4Both partners need to be involved. The data is clear: male factor contributes to 40-50% of infertility. The testing is easy. There is no reason to delay it.
  5. 5You have rights. The ART Act 2021 gives you rights as a patient that didn't exist before. Use them.

Questions to Ask Your Doctor 1. What is the prevalence of [your specific diagnosis, e.g., tubal factor] in your patient population? 2. Is your clinic registered under the ART Act 2021 and what is your registration number? 3. Can you provide your live birth rate per cycle broken down by age group? 4. Do you report outcomes data to the national registry? 5. What are the most common causes of infertility in couples like us that you see?

Medical Disclaimer This article is for informational and educational purposes only. Statistics cited represent population-level data and may not reflect your individual situation. Always consult a qualified fertility specialist for personalized evaluation and advice.

Join the GarbhSaathi community — a space for Indian couples navigating infertility to find honest information and peer support.